SLNO
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Soleno Therapeutics agreed to be acquired by Neurocrine as part of a strategic expansion dealApr 6, 2026
- Soleno Therapeutics announces entry into $100 million accelerated share repurchase agreementNov 11, 2025
- Soleno Therapeutics submits and gains EMA validation for marketing application of Diazoxide Choline extended-release tablets to treat hyperphagia in Prader-Willi syndromeMay 22, 2025
- Soleno Therapeutics reports that restarting VYKAT XR led to significant improvements in appetite and behavior in Prader-Willi Syndrome patientsMay 20, 2025